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Abstract Although T-type Ca2+ channels have been implicated
in numerous physiological functions, their regulations by protein
kinases have been obscured by con£icting reports. We investi-
gated the e¡ects of protein kinase C (PKC) on Cav3.2 T-type
channels reconstituted in Xenopus oocytes. Phorbol-12-myris-
tate-13-acetate (PMA) strongly enhanced the amplitude of
Cav3.2 channel currents (V3-fold). The augmentation e¡ects
were not mimicked by 4K-PMA, an inactive stereoisomer of
PMA, and abolished by preincubation with PKC inhibitors.
Our ¢ndings suggest that PMA upregulates Cav3.2 channel
activity via activation of oocyte PKC.
- 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
T-type Ca2þ channels have been implicated in a wide range
of physiological functions including neuronal ¢ring, cardiac
pacemaking, hormone secretion, muscle development and
contraction, and fertilization (reviewed in [1]). Neuronal
T-type channels are thought to contribute to many forms of
neural excitability, such as low threshold spikes that trigger
bursting ¢ring of action potentials, rebound bursting follow-
ing recovery from inactivation, and long-term potentiation
[2,3]. Furthermore, abnormal overexpression of T-type chan-
nels has been implicated in animal models of epilepsy and
cardiac hypertrophy [4^6].
Molecular cloning of three genes encoding T-type K1 sub-
units (Cav3.1, K1G; Cav3.2, K1H; Cav3.3, K1I) has provided
the tools with which to study the distribution and regulation
of T-type channels. The biophysical properties of expressed
T-type channels were very similar to those of native T-type
currents, suggesting the K1 subunit may function alone [1].
Among the three, the Cav3.2 showed nickel sensitive T-type
currents with fast activating and inactivating kinetics [7]. Ex-
pression of Cav3.2 mRNA was broadly detected throughout
the central nervous system, but also in peripheral organs in-
cluding heart, kidney, liver, and adrenal gland [8,9]. Thus,
Cav3.2 channels are thought to participate in neuronal excit-
ability, myocardial pacemaking activity, smooth muscle con-
traction, hormone secretion, and muscle di¡erentiation [1].
Regulation of T-type Ca2þ channels has been investigated to
understand their relevance to those physiological functions.
Although T-type channel activities are primarily regulated
by dynamic changes in cell membrane potential, recombinant
Cav3.2 channels have also been shown to be regulated by a
number of diverse signaling molecules, such as G-proteins [10]
and calmodulin-dependent protein kinase II [11].
The protein kinase C (PKC) family has been established to
be a prominent modulator of ion channel activity. Binding of
hormones or neurotransmitters to receptors can couple with
activation of Gq-proteins. Activated Gq stimulates phospho-
lipase C (PLC) which splits phosphatidylinositol-4,5-bisphos-
phate (PIP2) into diacylglycerol (DAG) and inositol 3-phos-
phate (IP3). The former activates PKC and the latter increases
cytoplasmic calcium levels by calcium release from internal
calcium stores [12]. Studies on PKC modulation of native
T-type channels have produced con£icting results. Currents
in rat neonatal ventricular myocytes were reported to be
stimulated 30% by phorbol-12-myristate-13-acetate (PMA)
or the related PKC stimulant, phorbol 12,13-dibutyrate
(PdBu), while the inactive analog 4K-PdBu had no e¡ect
[13]. Studies on rat dorsal root ganglion (DRG) neurons
found that PMA or 12-O-tetradecanoylphorbol-13-acetate
(TPA), inhibited the T-type current by V30%, and again
this e¡ect was not observed with the inactive analog [14]. In-
hibition of T-type currents by PKC stimulants has also been
observed in NIH-3T3 ¢broblasts [15]. Thus, we examined
whether PKC can modulate human T-type Cav3.2 channels
reconstituted in Xenopus oocytes. We report here that PMA,
a strong stimulant of PKC, can strongly augment T-type
Cav3.2 channel activities in Xenopus oocytes.
2. Materials and methods
2.1. Materials
4L-PMA, and calphostin C were obtained from Alexis (San Diego,
CA, USA). Staurosporine, calphostin C, and chelerythrine were pur-
chased from TOCRIS (Ballin, MO, USA). Most of the other chem-
icals used in this study were from Sigma (St. Louis, MO, USA).
2.2. Expression of the human Cav3.2 Ca
2+ channel in Xenopus oocytes
The cloning of the human Cav3.2 cDNA was reported previously
[8] and the Cav3.2 cDNA was subcloned into pGEM-HEA to improve
its expression in Xenopus oocytes [7]. Cav3.3 cDNA was linearized at
the 3P end with A£II. cRNA transcripts were synthesized in vitro
using T7 RNA polymerase according to the supplier’s protocol (Am-
bion, Austin, TX, USA).
Xenopus oocytes were prepared as described previously [16].
Brie£y, ovary lobes were surgically removed from female Xenopus
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laevis (Xenopus One, Ann Arbor, MI, USA) and manually torn into
small clusters of 5^10 oocytes in SOS solution (in mM: 100 NaCl,
2 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, 2.5 pyruvic acid, 50 Wg/ml
gentamicin, pH 7.6). The follicle membranes from oocytes were di-
gested by agitating in Ca2þ-free OR2 solution (in mM: 82.5 NaCl,
2.5 KCl, 1 MgCl2, 5 HEPES, pH 7.6) containing 2 mg/ml collagenase
type 1A (Sigma, St. Louis, MO, USA). Each oocyte was injected with
1^5 ng of cRNA in a volume of 50 nl using a Drummond Nanoject
pipette injector (Parkway, PA, USA) attached to a Narishige micro-
manipulator (Tokyo, Japan) under a dissecting microscope.
2.3. Electrophysiological recordings and data analysis
Barium currents (10 mM) were measured at room temperature 5^
8 days after cRNA injection using a two-electrode voltage clamp
ampli¢er (OC-725C, Warner Instruments, Hamden, CT, USA). Mi-
croelectrodes were pulled from borosilicate capillaries (Warner Instru-
ments, Hamden, CT, USA) using a pipette puller. The electrode re-
sistance was 0.2^1.0 M6 after being ¢lled with 3 M KCl. The Ba2þ
bathing solution contained (in mM): 10 Ba(OH)2, 90 NaOH, 1 KOH,
5 HEPES (pH 7.4 with methanesulfonic acid). The currents were
normally sampled at 5 kHz and low pass ¢ltered at 1 kHz using the
pClamp system (Digidata 1320A and pClamp 8; Axon Instruments,
Union City, CA, USA). Peak currents and exponential ¢ts to currents
were determined using Clamp¢t software (Axon instruments, Foster
City, CA, USA) and graphing of the data was obtained using Prism
software (GraphPad, San Diego, CA, USA). Statistical values are
given as meansQS.E.M. Data were tested for signi¢cance using Stu-
dent’s paired or unpaired t-tests.
3. Results
We investigated PKC e¡ects on human Cav3.2 T-type Ca2þ
channels expressed in Xenopus oocytes. This expression sys-
tem has been shown to be useful for studying the PKC mod-
ulation of recombinant Ca2þ channels [17]. Although oocytes
have been reported to express endogenous high and low vol-
tage-activated Ca2þ channels [18], we rarely detect any endog-
enous calcium channel activity in oocytes used for this study.
In contrast, oocytes injected with Cav3.2 (K1H) cRNA led to
the production of robust Ba2þ currents (s 500 nA) that could
be measured using a two-electrode voltage clamp ampli¢er.
Recorded currents displayed typical biophysical properties
of T-type Ca2þ currents such as low voltage threshold for
activation (about 360 mV), fast activation and inactivation
current kinetics, and a criss-crossing pattern between current
traces evoked by a voltage protocol. The current^voltage re-
lationship also resembled that of native T-type channels,
peaking at 320 mV during a voltage protocol, and displaying
an apparent reversal potential around +40 mV.
To examine whether recombinant Cav3.2 T-type channels
can be modulated by PKC, PMA (200 nM), a strong PKC
stimulant, was applied to the chamber where an oocyte was
located. Currents were evoked by a test potential to 330 mV
from a holding potential of 390 mV every 15 s. Without any
drug treatment, the current amplitude was stable with no sig-
ni¢cant run-up or run-down during the experimental period
(20^30 min). Addition of 200 nM PMA led to an increase in
current amplitude after a small lag (V2 min; Fig. 1A). This
lag is not due to solution exchange in the chamber, as control
experiments with Ni2þ showed a lag of only 15 s [7]. PMA-
induced stimulation of current amplitude continued for 20^
30 min before reaching a maximum level, where they re-
mained stable or sometimes ran down slowly (Figs. 1A and
3A). Representative traces before and 20 min after addition of
200 nM PMA e¡ect were overlapped (Fig. 1B) for compar-
ison, displaying that applied PMA strongly stimulated the
amplitudes of T-type currents about 2.6-fold.
The e¡ect of PMA on the Cav3.2 current^voltage (I^V)
relationship was examined with depolarizing voltage steps in
10 mV increments from 370 to +40 mV from a holding po-
tential of 390 mV. To control for variability in expression,
the peak amplitudes measured during each voltage step were
normalized to the maximum observed before addition of
PMA (Fig. 2A). PMA stimulated current at all test potentials.
To examine the e¡ect of PMA on the I^V curve, the currents
were also normalized to the maximum in each experimental
condition (Fig. 2B). PMA appeared to induce a slight shift in
the I^V towards more negative potentials. This e¡ect can also
be demonstrated by calculating the e¡ect of PMA at each test
potential (Fig. 2C). PMA stimulated currents recorded during
test potentials to 360 mV and 350 mV by 5.3- and 3.7-fold,
respectively (Fig. 2C), while currents recorded above 340 mV
were stimulated signi¢cantly less (V2.7-fold, n=10, P6 0.05).
Taken together, these data indicate that PMA produces a
robust increase in Cav3.2 currents and induces a small nega-
tive shift in the current^voltage curve.
One of the questions raised from the above results is
whether or not the enhancement e¡ects of PMA were medi-
ated by the activation of endogenous oocyte PKC. To address
this question, we tested if 4K-PMA, the inactive stereoisomer
of PMA, can mimic the stimulation e¡ects of PMA on Cav3.2
currents. When 200 nM 4K-PMA was superfused onto oocytes
expressing Cav3.2 channels, current amplitudes were not sig-
ni¢cantly altered (Fig. 3A).
Another way to test this hypothesis is to examine whether
Fig. 1. E¡ects of PMA on human Cav3.2 channel currents. Re-
combinant Cav3.2 channels were expressed in Xenopus oocytes and
their activity was measured using 10 mM Ba2þ as charge carrier.
Test pulses were delivered every 15 s to a test potential of 330 mV
from a holding potential of 390 mV. A: The time course of PMA’s
e¡ect on peak current amplitude is plotted. B: Representative cur-
rent traces taken before (a) and 20 min after (b) PMA treatment.
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PKC inhibitors, such as staurosporine, calphostin, or cheler-
ythrine, are capable of abrogating the PMA response. To
ensure complete inhibition of PKC, oocytes were preincu-
bated for 5^10 h in the presence of one of the PKC inhibitors,
200 nM staurosporine, 200 nM calphostin, or 500 nM cheler-
ythrine. Oocytes were then voltage clamped and the response
to 200 nM PMA was measured. All three PKC inhibitors
totally abolished the ability of PMA to stimulate current am-
plitudes (Fig. 3B,C, n=4^5). These data provide strong sup-
port for the hypothesis that PMA stimulated recombinant
T-type Cav3.2 currents via activation of endogenous oocyte
PKC.
The e¡ects of PMA on the biophysical properties of Cav3.2
channels were examined by comparing activation curves,
steady-state inactivation curves, and activation and inactiva-
tion time constants. As detected in the I^V relationships,
PMA shifted the activation curve toward the negative direc-
tion by 2.5 mV (V50 =336.61Q 0.78 vs. 339.11Q 0.72 V),
which was statistically signi¢cant (n=10, P6 0.05; Fig. 4A).
Similarly, PMA also shifted the steady-state inactivation by
33 mV (V50 =361.1Q 0.5 vs. 364.2 Q 0.49 V), which was sta-
tistically signi¢cant (n=10, P6 0.05; Fig. 4B). E¡ects on cur-
rent kinetics were evaluated by ¢tting the inward currents with
two exponentials, where one corresponds to channel activa-
tion and the other inactivation. Despite di¡erences in clamp
speed, the values obtained from oocytes are very similar to
those obtained during patch clamp recording of either native
or recombinant T-type channels expressed in 293 cells (re-
viewed in [1]). In all cases, T-type channels activate and in-
activate slowly near threshold (350 mV), but both kinetics are
faster at more depolarized potential, reaching apparent pla-
teaus around 0 mV (Fig. 4C,D). PMA slowed activation ki-
netics at threshold voltages, with no e¡ect on the voltage-in-
dependent value. In contrast, PMA-stimulated currents
inactivated faster at all test potentials measured.
4. Discussion
Studies on PKC modulation of native T-type channels have
reported con£icting results [13,19,20]. The recent cloning of
T-type channels allowed us to re-examine this issue in the
absence of background contaminating currents, and in a re-
cording con¢guration that does not disturb the intracellular
milieu. We report here that the Cav3.2 T-type calcium chan-
nels expressed in Xenopus oocytes can be potently modulated
by the PKC stimulator PMA, as evidenced by: (i) robust
increments of current amplitudes, (ii) lower threshold for
Cav3.2 channel activation, (iii) modi¢cations of activation
Fig. 2. E¡ect of PMA on the Cav3.2 current^voltage relationship. Peak currents elicited during test potentials to varying voltages were normal-
ized to the maximum observed. A: Peak currents were normalized to the maximum observed before the application of PMA (control, open
circles). Currents were also measured 20 min after exposure to 200 nM PMA, and normalized to the maximum observed under control condi-
tions (n=10). B: The data in A were normalized to the peak current observed in each experimental condition. C: From the same data we cal-
culated the fold stimulation by PMA at each test potential. Signi¢cant di¡erences where P6 0.01 are noted with **, while those at the P6 0.05
are noted with *.
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and inactivation time constants, and (iv) a negative shift in the
activation and steady-state inactivation curves. The stimula-
tory e¡ects were not mimicked by application of 4K-PMA, an
inactive isomer of PMA, and abolished after preincubation of
PKC inhibitors. These results illustrate a new regulation pat-
tern for T-type channels where PKC activation leads to potent
upregulation of calcium entry through Cav3.2 channels. PKC
has also been reported to upregulate recombinant high vol-
tage-activated Ca2þ channels that contain either Cav1.2,
Cav1.3, Cav2.2, or Cav2.3 K1 subunits [21^24].
The ability of PMA to shift the activation curve suggests
that PKC-dependent regulation would be more e¡ective at
low potentials around resting membrane potentials. Similarly,
calmodulin-dependent protein kinase II is also capable of
stimulating recombinant Cav3.2 activity although to a lesser
extent (30% at the peak of the I^V), and induces a shift in the
I^V to more negative potentials [25]. Modulation of threshold
currents may be of particular relevance to the ability of
Cav3.2 channels to regulate basal calcium levels via window
currents [26,27].
The whole cell current is a function of the number of chan-
nels in plasma membrane, their probability of opening, and
their single channel conductance. PMA produced a profound
e¡ect on current amplitude, with only modest e¡ects on ki-
netics, suggesting that the primary e¡ect of PMA is to in-
crease the apparent number of channels that open during
test depolarizations. Two likely mechanisms for this e¡ect
are an increase in the number of channels in the plasma mem-
brane, or an increase in their probability of opening. PKC
activation has been reported to alter the structure of the plas-
ma membrane of Xenopus oocytes, leading to a reduction in
total cell capacitance [28] (but see [17]). This would lead to a
decrease in T-type channel currents, rather than an increase.
Studies on the calmodulin-dependent kinase II regulation of
native Cav3.2 channels in bovine glomerulosa cells found that
stimulation was caused by a decrease in the number of blank
sweeps, with no change in single channel conductance, open
time distributions, or burst lengths [29]. Therefore it is likely
that PKC phosphorylation of Cav3.2 channels enhances their
ability to respond to test depolarizations, although single
channel studies are required to establish this mechanism.
One of the questions raised by our ¢ndings is whether the
PKC-dependent augmentation was dependent on the expres-
sion system. To address this question, we tested whether
PKC-dependent upregulation could be observed in mamma-
lian cell lines (293 or COS cells) transfected with Cav3.2
cDNA. PMA application (200 nM) did not modulate Cav3.2
currents in these cells in the whole cell recording mode (results
not shown). Therefore, as observed with native T-type chan-
nels, PKC regulation is dependent on the cell type used. Sim-
ilarly, PKA-dependent modulation of Cav1.2 varies between
cell types with no regulation in tracheal smooth muscle but
robust regulation in cardiac muscle, and regulation has been
di⁄cult to recapitulate with recombinant channels (reviewed
in [30]). Coexpression of an A-kinase anchor protein (AKAP)
with recombinant L-type channels has been shown to restore
PKA-dependent stimulation of Cav1.1 and Cav1.2 channels
[31,32]. Similarly, PKC anchoring proteins called RACKs (re-
ceptors for activated C kinases) were also shown to localize
PKC isoforms in the proximity to ion channels [32]. These
precedent ¢ndings suggest the possibility that regulation of
Cav3.2 channel activity by PKC might be dependent on the
di¡erential expression of RACKs between di¡erent cell types.
Alternatively divergent regulatory patterns of T-type Ca2þ
channels might be due to one or more of the following fac-
tors: (i) presence or absence of speci¢c PKC isoforms; (ii)
presence of speci¢c T-type channel isoforms; (iii) unidenti¢ed
regulatory protein(s) such as RACKs; and (iv) di¡erential
expression of as yet to be identi¢ed auxiliary subunits of
T-type channels. Among these possibilities, we would like to
rule out the second one because both the rat Cav3.1 and
Cav3.3 measured in Xenopus oocytes were also potently
stimulated by PMA (Park and Lee, unpublished data). Taken
together, this study provides strong evidence that T-type cur-
rents can be potently regulated by PKC in Xenopus oocytes.
Future studies will examine the mechanisms for this regula-
tion and why they di¡er between cell types, which may pro-
vide insights into the physiological role of T-type channels.
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Fig. 3. Selectivity of the PMA response. A: Time course showing
the responses to the stereoisomers of PMA. In contrast to PMA,
which strongly augmented Cav3.2 currents, the inactive isomer of
PMA, 4K-PMA, did not augment currents. B: Time course of PMA
e¡ects with oocytes preincubated with various PKC inhibitors. Oo-
cytes expressing Cav3.2 channels were incubated for 5^10 h in SOS
solution including either 200 nM staurosporine, 200 nM calphostin
C, or 500 nM chelerythrine. The currents measured from these
oocytes were normalized to the initial current amplitudes, and then
averaged (n=4^5).
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